Next Article in Journal
Phase II Study of Nanoliposomal Irinotecan (Nal-IRI) with 5-Fluorouracil and Leucovorin in Refractory Advanced High-Grade Neuroendocrine Cancer of Gastroenteropancreatic (GEP) or Unknown Origin
Previous Article in Journal
Patient Acceptability of the First Integrative Pediatric Oncology Unit in Spain—The Pediatric Cancer Center Barcelona Experience: A Retrospective Study
 
 
Article

Article Versions Notes

Cancers 2025, 17(2), 223; https://doi.org/10.3390/cancers17020223
Action Date Notes Link
article pdf uploaded. 11 January 2025 13:59 CET Version of Record https://www.mdpi.com/2072-6694/17/2/223/pdf-vor
article supplementary file uploaded. 11 January 2025 13:59 CET - https://www.mdpi.com/2072-6694/17/2/223#supplementary
article xml file uploaded 13 January 2025 08:22 CET Original file -
article xml uploaded. 13 January 2025 08:22 CET Update https://www.mdpi.com/2072-6694/17/2/223/xml
article pdf uploaded. 13 January 2025 08:22 CET Updated version of record https://www.mdpi.com/2072-6694/17/2/223/pdf
article html file updated 13 January 2025 08:25 CET Original file -
article html file updated 24 June 2025 12:11 CEST Update https://www.mdpi.com/2072-6694/17/2/223/html
Back to TopTop